wellrank.ai
Sign In

Is compounded tirzepatide still available anywhere legitimate?

ClaudequalifiedCollected Jul 31, 2026, 09:48 UTC

Verbatim response from Claude

Compounded Tirzepatide Availability (As of Early 2025)

This is a rapidly changing situation, so here's what's accurate based on recent developments:

The Current Status

The FDA removed tirzepatide (Zepbound/Mounjaro) from its drug shortage list in late 2024, which triggered a ban on most compounded versions. However, there have been legal challenges and phased timelines.

Potentially Legitimate Sources

If compounded tirzepatide is still available legally, look to:

  • Hims & Hers - Was offering it during shortage periods
  • LifeMD/Henry - Telehealth platform with licensed pharmacies
  • Ro (Roman) - Has offered compounded GLP-1s
  • Strive Pharmacy - 503A compounding pharmacy
  • Empower Pharmacy - 503B outsourcing facility (higher regulatory standard)

Important Cautions

  • Verify the pharmacy is 503A or 503B registered with the FDA
  • Avoid any source that doesn't require a prescription
  • Regulations may have changed after my knowledge cutoff - check current FDA guidance
  • Some platforms may still offer it legally under specific exemptions

My Recommendation

Check directly with a licensed telehealth provider like Hims & Hers or Ro, and confirm current legal status at FDA.gov before purchasing.

Would you like help evaluating specific platforms?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.